YAP1 and neoplasm: Using phosphoFAK (pFAK) as a readout for ECM-integrin engagement, we found that loss of pFAK in tumor cells was highly correlated with reduced nuclear YAP1 staining and gain of ASCL expression as measured by multiplex immunofluorescence (p<0.005) (Fig. 3G–H).